RESI San Francisco Panel Announcement: Diagnostic Investors

1 Dec

By Cole Bunn, Senior Research Analyst, LSN

cole-wp

As we are quickly approaching RESI@JPM, LSN is happy to announce the Diagnostic Investors panel. Entrepreneurs seeking to secure funding for their diagnostic technologies arguably have the toughest job of all the early-stage biotech/medtech folks, given the wide variety of diagnostic technologies and services along with a complex regulatory and reimbursement system.

Whether you are looking for guidance on how to court a venture investor or how to engage a strategic partner, you can hear from both on how to best prepare to present to and work with organizations like theirs.

Diagnostics panelists will include the following:

The panelists will share their perspective and tactical guidance for shepherding a diagnostic at the early stages of development through the dynamic healthcare environment to an eventual exit.

By registering for RESI San Francisco, you’ll be able to listen to the Diagnostics panel live in person, and experience numerous opportunities to expand your network in the life sciences and to learn more about the fundraising process.

resi-san-francisco-2017

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: